🚨NEW: The FDA has approved #revumenib for kids & adults with #leukemia that's come back after treatment & whose cancer carries a KMT2A translocation. MSK's Dr. Eytan Stein led the trial that brought about the drug's approval. Learn more: bit.ly/3CBEk9n